Literature DB >> 21366826

Tissue distribution of dexamethasone in feline ocular structures following single topical application of dexamethasone as an ointment or suspension.

Julia Bessonova1, Andrea Meyer-Lindenberg, Wolfgang Bäumer, Manfred Kietzmann.   

Abstract

OBJECTIVE: To compare the dexamethasone concentration in various structures of the feline eye following a single topical application of dexamethasone as an ophthalmic ointment or suspension. ANIMALS STUDIED: Nineteen cats, euthanized due to reasons not related to this study, were selected and their ocular health status evaluated. Selected animals were treated with dexamethasone ointment or suspension. PROCEDURE: The concentration of dexamethasone was determined in the following structures of the eye: third eyelid, cornea, aqueous humor, iris, lens, vitreous body, and choroid/retina. The dexamethasone concentration in the eye was measured by radioimmunoassay. The applied amount of dexamethasone was 0.05 mg in 0.05 mL Isopto Dex(®) ophthalmic suspension and 0.05 mL Isopto Dex(®) ophthalmic ointment, respectively. Cats were treated once with ointment or suspension and were euthanized 3 h or 6 h after treatment.
RESULTS: At 3 h after topical administration the highest concentrations of dexamethasone were measured in the anterior structures of the eye. The concentrations after application of ointment and suspension were comparable. However, 6 h after administration, the concentrations decreased after administration of suspension and increased further after administration of the ointment, leading to significantly higher concentrations of dexamethasone in the third eyelid, cornea and choroid/retina after treatment with ointment.
CONCLUSION: Therapeutically relevant concentrations of dexamethasone after a single topical administration were only achieved in the anterior structures of the eye. Six hours after application there was a substantially higher amount of dexamethasone in the anterior structures of cat eyes treated with ophthalmic ointment compared to ophthalmic suspension.
© 2011 American College of Veterinary Ophthalmologists.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21366826     DOI: 10.1111/j.1463-5224.2010.00851.x

Source DB:  PubMed          Journal:  Vet Ophthalmol        ISSN: 1463-5216            Impact factor:   1.644


  2 in total

1.  Retinal Delivery of the Protein Kinase C-β Inhibitor Ruboxistaurin Using Non-Invasive Nanoparticles of Polyamidoamine Dendrimers.

Authors:  Rehab A Alshammari; Fadilah S Aleanizy; Amal Aldarwesh; Fulwah Y Alqahtani; Wael A Mahdi; Bushra Alquadeib; Qamraa H Alqahtani; Nazrul Haq; Faiyaz Shakeel; Hosam G Abdelhady; Ibrahim A Alsarra
Journal:  Pharmaceutics       Date:  2022-07-11       Impact factor: 6.525

2.  Penetration of topically administered dexamethasone disodium phosphate and prednisolone acetate into the normal equine ocular fluids.

Authors:  Hanneke Hermans; Els M H van den Berg; Inge J M Slenter; Dax J C Vendrig; Lilian J L de Nijs-Tjon; Johannes C M Vernooij; Harold Brommer; Michael H Boevé; Ronette Gehring
Journal:  Equine Vet J       Date:  2021-11-21       Impact factor: 2.692

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.